Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Dow
UBS
Baxter
US Army
Mallinckrodt
Boehringer Ingelheim
Cipla
Cantor Fitzgerald

Generated: January 17, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,511,046

« Back to Dashboard

Which drugs does patent 9,511,046 protect, and when does it expire?

Patent 9,511,046 protects ABRAXANE and is included in one NDA.

This patent has twelve patent family members in twelve countries.

Summary for Patent: 9,511,046
Title:Methods of treating pancreatic cancer
Abstract: Provided herein are methods for the treatment of metastatic pancreatic cancer comprising administration of a composition comprising nanoparticles comprising a taxane (such as paclitaxel) and a carrier protein in combination with gemcitabine.
Inventor(s): Desai; Neil P. (Los Angeles, CA), Renschler; Markus (San Francisco, CA)
Assignee: ABRAXIS BIOSCIENCE, LLC (Los Angeles, CA)
Application Number:13/794,480
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;

Drugs Protected by US Patent 9,511,046

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abraxis Bioscience ABRAXANE paclitaxel FOR SUSPENSION;IV (INFUSION) 021660-001 Jan 7, 2005 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF PANCREATIC CANCER ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 9,511,046

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013203699 ➤ Try a Free Trial
Canada 2897589 ➤ Try a Free Trial
China 105025893 ➤ Try a Free Trial
European Patent Office 2943192 ➤ Try a Free Trial
Hong Kong 1216853 ➤ Try a Free Trial
Israel 239739 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Covington
Cerilliant
Federal Trade Commission
Fish and Richardson
Chubb
UBS
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.